Skip to content

China mRNA Covid Shot Gets First Ever Approval, Just Not at Home

  • Indonesia clears Walvax vaccine for people aged 18 and older
  • China is yet to approve any mRNA vaccine for use domestically
Updated on

A Chinese-developed mRNA Covid vaccine got its first ever emergency use authorization from Indonesian authorities, a tentative step in China’s efforts to gain ground on Western inoculations widely used around the world.

The shot, named AWcorna, was co-developed by Walvax Biotechnology Co, Suzhou Abogen Biosciences Co. and the Chinese military and has been cleared for use in people aged 18 and older, Walvax said in a statement. The halal-certified vaccine can be used as either a primary or booster dose, it said.